We all want to make the best decisions in our investing, but how do we know where and how to allocate our funds? …
Written by Daniel Cohen and Scott Matusow Lately, many early stage developmental biotech companies have been going on some seriously epic runs. Karuna …
Texas Mineral Resources (TMRC) is a unique play in the rare earth space, which has been developing a new methodology to extract these …
Written by Danny Cohen of stockmatusow.com BiolineRx (BLRX) is slated to report on complete data at the European Society for Medical Oncology (ESMO) …
Written by Dan Cohen and Scott Matusow Cytokinetics (NASDASQ:CYTK) looks to turn around their fortunes following last year’s unsuccessful readout of Tirasemtiv in …
Written by Dan Cohen In the wake of recently revealed abstracts from the 2018 ASCO meeting, Jounce therapeutics (NASDAQ:JNCE) stock price recently took …
Written by Danny Cohen and Scott Matusow The biotech “run-up” trade has always attracted a wide-array of traders looking to take advantage of …
Written by Danny Cohen And Scott Matusow This past weekend at The Society for Immunotherapy of Cancer (SITC) Calithera Biosciences Inc (NASDAQ:CALA) presented a …
Written by Dan Cohen and Scott Matusow from Stockmatusow.com.
Written by Dan Cohen and Scott Matusow Currently, we are in the midst of a dramatic shift in the field of biotechnology and …